Rosen Law Firm Investigates Securities Class Action for MoonLake Immunotherapeutics Investors
On October 12, 2025, the Rosen Law Firm, an esteemed legal entity known for advocating for investor rights, announced its investigation into securities claims concerning MoonLake Immunotherapeutics, a biotechnology firm listed on NASDAQ under the ticker MLTX. This inquiry arises from troubling allegations suggesting that MoonLake may have distributed significantly misleading business information that misled investors.
The Context
Investors who acquired securities of MoonLake Immunotherapeutics could be entitled to compensation due to the ramifications of the alleged misinformation, with no upfront costs incurred through a contingency fee arrangement. The Rosen Law Firm is actively preparing a class action lawsuit aimed at recovering financial losses suffered by investors during this unsettling period.
MoonLake made headlines on September 29, 2025, when it filed a current report with the US Securities and Exchange Commission (SEC). The report included a press release concerning outcomes from the company's VELA-2 clinical trial. MoonLake disclosed that unforeseen issues in the placebo group skewed the results, preventing the trial from reaching statistical significance for its primary endpoint. Following this disclosure, MoonLake's stock experienced a drastic decline, plummeting by an astonishing 89.9% within the same trading day.
Taking Action
For affected investors wishing to join the class action, the Rosen Law Firm encourages them to visit their official website or directly contact attorney Phillip Kim, Esq. via phone or email for further information regarding the investigation and their potential participation in the lawsuit.
Why Choose Rosen Law Firm?
The Rosen Law Firm emphasizes the importance of selecting competent legal counsel, especially for class actions in the securities domain. Their history showcases successful leadership roles in litigation, setting them apart from other firms. Many announcements made by lesser-known firms often lack the expertise capable of effectively navigating securities class actions.
The Rosen Law Firm has a proven track record of significant achievements, having secured the largest settlement in a securities class action against a Chinese firm, among other notable victories. Additionally, they were recognized as the top firm for securities class action settlements in 2017 and have consistently remained a top contender since 2013, with hundreds of millions recovered for investors. Notably, in 2019, they recovered over $438 million for their clients, further solidifying their reputation in the legal field. Laurence Rosen, a founding partner, was even honored as a Titan of the Plaintiffs' Bar by Law360 in 2020, highlighting their commitment to advocacy in investor rights.
For further updates on this investigation and other important news, the Rosen Law Firm encourages following their social media platforms on LinkedIn, Twitter, and Facebook.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll-Free: (866) 767-3653
Fax: (212) 202-3827
Email:
[email protected]
Website: www.rosenlegal.com
Disclaimer: This firm engages in attorney advertising. Previous results do not guarantee similar outcomes.